ASUS has announced that its VivoWatch ECG app has received certification from the Food and Drug Administration Thailand (FDA Thai), marking a significant advancement in smart healthcare innovation within the country. This regulatory approval represents a key milestone for ASUS, highlighting the company’s growing influence in the global digital health space and reinforcing its dedication to developing medical-grade technology. Joe Hsieh, Chief Operating Officer and Global Senior Vice President of ASUS, emphasized the company’s mission to empower both individuals and healthcare providers with cutting-edge health monitoring tools. He stated that the certification not only validates ASUS’s technological capabilities but also strengthens its commitment to making smart, reliable health solutions more accessible worldwide. The ECG app, designed for use with the ASUS VivoWatch, enables users to intuitively and efficiently monitor their heart health. By simply placing a fingertip on the watch-face sensors for 30 seconds, users can obtain a real-time electrocardiogram (ECG) reading. These results are displayed directly on the watch and can be easily shared with healthcare professionals, enhancing communication and potentially supporting early diagnosis and improved care management. This development underlines ASUS’s dedication to integrating advanced health-monitoring features into consumer technology, making proactive healthcare more seamless and accessible.
Ready for personal and institutional use
The ECG functionality enabled by ASUS VivoWatch is ideal for individual consumers as well as for use in hospitals, clinics and any other healthcare setting. It can also be integrated into business-to-business (B2B) solutions to enhance VIP patient care and support premium health management services.
In addition to the newly activated ECG function, ASUS VivoWatch also supports blood pressure monitoring. This means that VivoWatch enables users to track two essential cardiovascular indicators simultaneously. With accurate, real-time date, the solution helps detect potential health issues, making it a valuable asset for institutions aiming to improve both care quality and operational efficiency.